INSILICO Adds 6.60 Million Shares in July, Bringing Issued Share Count to 582.44 Million

Bulletin Express08-06

InSilico Medicine Cayman TopCo (INSILICO) filed its Monthly Return for the period ended 31 July 2026, detailing changes in share capital and equity incentives.

Key figures • Authorised share capital remained unchanged at 1.27 billion ordinary shares with a par value of USD 0.0000005, representing total authorised capital of USD 635. • Issued shares (excluding treasury shares) rose by 6.60 million to 582.44 million. No treasury shares were held or cancelled. • The company confirmed compliance with the minimum public-float threshold of 15 % under Hong Kong listing rules.

Drivers of share issuance • Share-option exercises under pre-IPO equity incentive plans accounted for 4.53 million new shares, generating HKD 32.67 million in cash proceeds. • Restricted Share Units (RSUs) contributed a further 2.07 million shares, split between pre-IPO plans (1.65 million) and the post-IPO RSU scheme adopted on 15 December 2025 (0.42 million).

Outstanding equity incentives • Post-exercise, 20.49 million share options remain outstanding under pre-IPO plans. • The post-IPO share-option scheme holds capacity for up to 24.16 million shares, though none were granted or exercised during the month. • Shares eligible for future issuance under outstanding options and RSUs total 41.39 million.

No warrants, convertible securities, or other share movements were reported for the month.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1134662320?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-06 17:26","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1134662320","market":"us","top_or_hot":-1,"title":"INSILICO Adds 6.60 Million Shares in July, Bringing Issued Share Count to 582.44 Million","media":"Bulletin Express","content":"<p>InSilico Medicine Cayman TopCo (INSILICO) filed its Monthly Return for the period ended 31 July 2026, detailing changes in share capital and equity incentives.</p>\n<p>Key figures  \n• Authorised share capital remained unchanged at 1.27 billion ordinary shares with a par value of USD 0.0000005, representing total authorised capital of USD 635.  \n• Issued shares (excluding treasury shares) rose by 6.60 million to 582.44 million. No treasury shares were held or cancelled.  \n• The company confirmed compliance with the minimum public-float threshold of 15 % under Hong Kong listing rules.</p>\n<p>Drivers of share issuance  \n• Share-option exercises under pre-IPO equity incentive plans accounted for 4.53 million new shares, generating HKD 32.67 million in cash proceeds.  \n• Restricted Share Units (RSUs) contributed a further 2.07 million shares, split between pre-IPO plans (1.65 million) and the post-IPO RSU scheme adopted on 15 December 2025 (0.42 million).</p>\n<p>Outstanding equity incentives  \n• Post-exercise, 20.49 million share options remain outstanding under pre-IPO plans.  \n• The post-IPO share-option scheme holds capacity for up to 24.16 million shares, though none were granted or exercised during the month.  \n• Shares eligible for future issuance under outstanding options and RSUs total 41.39 million.</p>\n<p>No warrants, convertible securities, or other share movements were reported for the month.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>INSILICO Adds 6.60 Million Shares in July, Bringing Issued Share Count to 582.44 Million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nINSILICO Adds 6.60 Million Shares in July, Bringing Issued Share Count to 582.44 Million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-06 17:26</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>InSilico Medicine Cayman TopCo (INSILICO) filed its Monthly Return for the period ended 31 July 2026, detailing changes in share capital and equity incentives.</p>\n<p>Key figures  \n• Authorised share capital remained unchanged at 1.27 billion ordinary shares with a par value of USD 0.0000005, representing total authorised capital of USD 635.  \n• Issued shares (excluding treasury shares) rose by 6.60 million to 582.44 million. No treasury shares were held or cancelled.  \n• The company confirmed compliance with the minimum public-float threshold of 15 % under Hong Kong listing rules.</p>\n<p>Drivers of share issuance  \n• Share-option exercises under pre-IPO equity incentive plans accounted for 4.53 million new shares, generating HKD 32.67 million in cash proceeds.  \n• Restricted Share Units (RSUs) contributed a further 2.07 million shares, split between pre-IPO plans (1.65 million) and the post-IPO RSU scheme adopted on 15 December 2025 (0.42 million).</p>\n<p>Outstanding equity incentives  \n• Post-exercise, 20.49 million share options remain outstanding under pre-IPO plans.  \n• The post-IPO share-option scheme holds capacity for up to 24.16 million shares, though none were granted or exercised during the month.  \n• Shares eligible for future issuance under outstanding options and RSUs total 41.39 million.</p>\n<p>No warrants, convertible securities, or other share movements were reported for the month.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03696","symbol_name":"英矽智能","start_time":0,"source_url":"","article_id":"1134662320","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1134662320","pubTimestamp":1786008391,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"InSilico Medicine Cayman TopCo (INSILICO) filed its Monthly Return for the period ended 31 July 2026, detailing changes in share capital and equity incentives. Key figures   • Authorised share...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03696":"英矽智能"},"translate_title":"INSILICO 7 月份增持 660 万股，使已发行股票数量达到 5.8244 亿股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03696":1},"content_text":"InSilico Medicine Cayman TopCo (INSILICO) filed its Monthly Return for the period ended 31 July 2026, detailing changes in share capital and equity incentives.\nKey figures  \n• Authorised share capital remained unchanged at 1.27 billion ordinary shares with a par value of USD 0.0000005, representing total authorised capital of USD 635.  \n• Issued shares (excluding treasury shares) rose by 6.60 million to 582.44 million. No treasury shares were held or cancelled.  \n• The company confirmed compliance with the minimum public-float threshold of 15 % under Hong Kong listing rules.\nDrivers of share issuance  \n• Share-option exercises under pre-IPO equity incentive plans accounted for 4.53 million new shares, generating HKD 32.67 million in cash proceeds.  \n• Restricted Share Units (RSUs) contributed a further 2.07 million shares, split between pre-IPO plans (1.65 million) and the post-IPO RSU scheme adopted on 15 December 2025 (0.42 million).\nOutstanding equity incentives  \n• Post-exercise, 20.49 million share options remain outstanding under pre-IPO plans.  \n• The post-IPO share-option scheme holds capacity for up to 24.16 million shares, though none were granted or exercised during the month.  \n• Shares eligible for future issuance under outstanding options and RSUs total 41.39 million.\nNo warrants, convertible securities, or other share movements were reported for the month.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1134662320","isCrawlerRequest":true}